 |
|
Treatment of Tardive DyskinesiaII. Short-Term Efficacy of Dopamine-Blocking Agents Haloperidol and Thiopropazate
Hajime Kazamatsuri, MD;
Ching-piao Chien, MD;
Jonathan O. Cole, MD
Arch Gen Psychiatry. 1972;27(1):100-103.
Abstract
Based on the hypothesis that an enhanced dopaminergic activity in the basal ganglia may play a major role in tardive dyskinesia, the clinical efficacy of two dopamine-blocking agents, haloperidol (Haldol) and thiopropazate dihydrochloride (Dartal), for the short-term treatment of tardive dyskinesia was studied on 20 patients for four weeks. Both drugs were shown to have marked antidyskinetic effects in over a half of the patients. Improvements of dyskinesia were not always accompanied by development of reversible extrapyramidal symptoms. These results, together with the findings obtained in the previous study, appear to support the above-mentioned hypothesis, and suggest another approach to the symptomatic control of tardive dyskinesia through neurochemical regulation, although the clinical practicability of these drug regimens over a longer period of time is not established and needs further investigation.
Author Affiliations
Boston
From Boston State Hospital (Drs. Kazamatsuri, Chien, and Cole) and Tufts University Medical School, Boston (Drs. Chien and Cole). Dr. Kazamatsuri was on leave from Tokyo University School of Medicine at the time this paper was written. He is currently a professor of Teikyo University School of Medicine, Tokyo.
Footnotes
Accepted for publication Sept 27, 1971.
Reprint requests to Boston State Hospital, 591 Morton St, Boston 02124 (Dr. Chien).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Therapeutic Strategies Against Tardive Dyskinesia: Two Decades of Experience
Jeste and Jed Wyatt
Arch Gen Psychiatry 1982;39:803-816.
ABSTRACT
Metoclopramide Treatment of Tardive Dyskinesia
Karp et al.
JAMA 1981;246:1934-1935.
ABSTRACT
Relationship Between the B-Mitten EEG Pattern and Tardive Dyskinesia: A Pilot Control Study
Wegner et al.
Arch Gen Psychiatry 1979;36:599-603.
ABSTRACT
The Assessment of Tardive Dyskinesia
Gardos et al.
Arch Gen Psychiatry 1977;34:1206-1212.
ABSTRACT
Spontaneous Oral Dyskinesia: Results of Treatment With Tetrabenazine, Pimozide, or Both
Pakkenberg and Fog
Arch Neurol 1974;31:352-353.
ABSTRACT
Tardive Dyskinesia and Drug Therapy in Geriatric Patients
Crane and Smeets
Arch Gen Psychiatry 1974;30:341-343.
ABSTRACT
Neurological Syndromes Associated With Antipsychotic Drug Use: A Special Report
FREEDMAN
Arch Gen Psychiatry 1973;28:463-467.
ABSTRACT
Treatment of Tardive Dyskinesia: III. Clinical Efficacy of a Dopamine Competing Agent, Methyldopa
Kazamatsuri et al.
Arch Gen Psychiatry 1972;27:824-827.
ABSTRACT
Therapeutic Approaches to Tardive Dyskinesia: A Review of the Literature
Kazamatsuri et al.
Arch Gen Psychiatry 1972;27:491-499.
ABSTRACT
|
